- Condition: Uncomplicated Urogenital Gonorrhea
Intervention: Drug: solithromycin
Sponsors: Cempra Pharmaceuticals; Cempra Pharmaceuticals
Recruiting - verified May 2012 - Condition: Overactive Bladder Syndrome
Intervention: Procedure: retrospective data analysis
Sponsors: University of Zurich; University of Zurich
Not yet recruiting - verified March 2012 - Conditions: Pregnancy; Sexually Transmitted Infections
Interventions: Behavioral: BUtiful. Be yoU! Talented, Informed, Fearless, Uncompromised, Loved; Behavioral: DIVAS. Diversity, Individuality, Vitality, Activity and Strong.
Sponsors: Tulane University Health Sciences Center; Tulane University Health Sciences Center; Department of Health and Human Services
Not yet recruiting - verified April 2012 - Condition: HIV Prevention
Interventions: Other: Testing and Counseling; Behavioral: Brief Motivational Interviewing; Behavioral: Integrated Family and Cognitive Behavioral Therapy
Sponsors: University of Florida; University of Florida; National Institute on Drug Abuse (NIDA)
Recruiting - verified March 2012 - Condition: Infection
Intervention: Device: STD Diagnostic Kit (Identigene)
Sponsors: Identigene; Identigene; Lifetree Clinical Research
Recruiting - verified November 2011 - Conditions: HIV; Syphilis; Gonorrhea; Chlamydia
Interventions: Behavioral: Mujer Segura; Behavioral: CENSIDA counseling program
Sponsors: University of California, San Diego; University of California, San Diego; National Institute of Mental Health (NIMH)
Recruiting - verified November 2011 - Conditions: Gonorrhea; Chlamydia; Trichomoniasis; Syphilis; HIV Infections
Intervention: Behavioral: Intervention
Sponsors: University of Kentucky; University of Kentucky; National Institute of Mental Health (NIMH)
Not yet recruiting - verified September 2011 - Condition: HIV
Interventions: Behavioral: Standard HIV prevention messages; Behavioral: 5 counselor-delivered sessions; Drug: ARVs with raltegravir and emtricitabine/tenofovir disoproxil fumarate
Sponsors: University of North Carolina, Chapel Hill; William (Bill) C. Miller, MD
Not yet recruiting - verified October 2011 - Conditions: HIV; Sexually Transmitted Infections
Interventions: Behavioral: Connect 'n Unite; Behavioral: Wellness Promotion
Sponsors: Columbia University; Columbia University; National Institute on Drug Abuse (NIDA)
Not yet recruiting - verified January 2012 - Conditions: Chlamydia Infection; Gonococcal Infection; Sexually Transmitted Diseases
Intervention:
Sponsors: University of California, San Francisco; University of California, San Francisco; Abbott Molecular
Not yet recruiting - verified April 2012 - Condition: Contraception
Intervention: Device: Woman's Condom
Sponsors: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Active, not recruiting - verified February 2012 - Conditions: Anal Cancer; Nonneoplastic Condition; Penile Cancer; Precancerous Condition
Interventions: Biological: quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine; Other: laboratory biomarker analysis
Sponsors: National Cancer Institute (NCI); AIDS Associated Malignancies Clinical Trials Consortium; National Cancer Institute (NCI)
Recruiting - verified February 2012 - Conditions: Hazardous Alcohol Use; Binge Drinking; High Risk Sexual Behaviors; HIV Risk Reduction; HIV Infection
Interventions: Behavioral: Computerized brief alcohol intervention with IVR booster calls; Behavioral: Computer delivered brief alcohol intervention; Behavioral: Attention Control
Sponsors: Johns Hopkins University; Johns Hopkins University; National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Not yet recruiting - verified June 2011 - Condition: Urogential Chlamydia Trachomatis Infection
Interventions: Drug: Doxycyline Hyclate tablet; Drug: Vibramycin (doxycyline hyclate) capsule
Sponsors: Warner Chilcott; Warner Chilcott
Completed - verified December 2011 - Condition: Intermittent Preventive Treatment In Pregnancy (IPTp)
Interventions: Drug: Azithromycin plus chloroquine; Drug: sulfadoxine-pyrimethamine
Sponsors: Pfizer; Pfizer
Recruiting - verified May 2012 - Condition: Mucopurulent Cervicitis
Interventions: Drug: Azithromycin; Drug: Placebo; Drug: Cefixime
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Terminated - verified January 2012 - Conditions: Sexually Transmitted Infections; HIV Infections
Intervention:
Sponsors: University of Mississippi Medical Center; University of Mississippi Medical Center; Mississippi State Department of Health
Suspended - verified July 2010 - Condition: HIV Infections
Interventions: Other: CARE+ Kenya brief computer risk assessment session; Other: CARE+ Kenya computer counseling session
Sponsors: New York University; New York University; Indiana University; Moi University
Recruiting - verified February 2012 - Condition: Gonococcal Infections
Interventions: Drug: Azithromycin; Drug: Gemifloxacin; Drug: Gentamicin
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified November 2011 - Condition: HIV Infections
Intervention:
Sponsors: National Institute of Mental Health (NIMH); National Institute of Mental Health (NIMH)
Recruiting - verified April 2009 - Condition: HIV-infection/Aids
Intervention: Behavioral: Cognitive-behavioral HIV/STD risk reduction
Sponsors: Mississippi State University; Mississippi State University; National Institute on Drug Abuse (NIDA)
Completed - verified October 2011 - Condition: Human Papillomavirus
Interventions: Other: Cohort: 3000 men examined every 6 months for 4 years.; Other: Pilot study: 150 men examined every 6 months for 4 years.
Sponsors: H. Lee Moffitt Cancer Center and Research Institute; H. Lee Moffitt Cancer Center and Research Institute; National Cancer Institute (NCI)
Active, not recruiting - verified March 2012 - Condition: HIV Infections
Intervention: Behavioral: IMARA HIV Prevention Intervention
Sponsors: Emory University; Emory University; Centers for Disease Control and Prevention
Active, not recruiting - verified March 2012 - Condition: HIV Infections
Intervention:
Sponsors: Kaohsiung Medical University Chung-Ho Memorial Hospital; Kaohsiung Medical University Chung-Ho Memorial Hospital; Centers for Disease Control and Prevention
Completed - verified December 2011 - Condition: Gonorrhea
Intervention:
Sponsors: University of Florida; University of Florida
Completed - verified February 2009 - Condition: Bacterial Vaginosis
Interventions: Other: No Intervention; Drug: Metronidazole
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified November 2011 - Conditions: HIV Infections; Sexually Transmitted Diseases
Interventions: Behavioral: Social Skills Training; Behavioral: Mass media; Behavioral: Control
Sponsors: University of Pennsylvania; University of Pennsylvania; National Institute of Mental Health (NIMH)
Completed - verified January 2012 - Condition: HIV
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified July 2011 - Condition: Sexually Transmitted Diseases
Interventions: Behavioral: Afiya HIV Prevention Intervention; Behavioral: Afiya HIV prevention intervention
Sponsors: Emory University; Emory University; National Institutes of Health (NIH)
Active, not recruiting - verified March 2012 - Conditions: HIV Infections; Gonorrhea; Chlamydial Infections; Genital Herpes
Intervention: Drug: PRO 2000/5
Sponsors: Endo Pharmaceuticals; Endo Pharmaceuticals; Medical Research Council; Department for International Development, United Kingdom
Completed - verified July 2011 - Conditions: HIV Infections; AIDS; Sexually Transmitted Diseases; HIV Seroconversion
Intervention: Drug: Carraguard (PC-515)
Sponsors: Population Council; Population Council; United States Agency for International Development (USAID); Bill and Melinda Gates Foundation
Completed - verified May 2012 - Condition: HIV Infections
Interventions: Drug: BufferGel; Drug: PRO 2000/5 Gel; Drug: Placebo gel
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute on Drug Abuse (NIDA); National Institute of Mental Health (NIMH); HIV Prevention Trials Network
Completed - verified April 2012
 |
Join Clinical Trials in Connecticut |
